Literature DB >> 3312559

Induction of petite mutation with acriflavine and elevated temperature in Candida albicans.

S Aoki1, S Ito-Kuwa.   

Abstract

A method of inducing respiratory deficient (petite) mutation in Candida albicans (which has been previously classed as a petite-negative yeast) and characteristics of some isolated mutants are reported. When grown at 42 degrees C in the presence of a cytoplasmic mutagen (acriflavine), C. albicans exhibited diauxie-like biphasic growth. Mutants which were unable to grow on a non-fermentable substrate, glycerol, were isolated from the above culture at a frequency of less than 1%. The simultaneous action of both acriflavine and a supraoptimal temperature of 42 degrees C was required to induce respiratory mutation. The respiratory mutants were separated into two groups: i. mutants exhibiting a complete cytochrome spectrum but with low respiratory activity and ii. those deficient in cytochrome aa3. Further characterization of their respiratory activity, colony morphology, mitochondrial morphology and growth manner supported the evidence that members of the latter group can be regarded as petite mutants.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3312559     DOI: 10.1080/02681218780000611

Source DB:  PubMed          Journal:  J Med Vet Mycol        ISSN: 0268-1218


  6 in total

1.  Isolation and characterization of respiration-deficient mutants from the pathogenic yeast Candida albicans.

Authors:  M A Hatab; P A Whittaker
Journal:  Antonie Van Leeuwenhoek       Date:  1992-04       Impact factor: 2.271

2.  Candida albicans mutants deficient in respiration are resistant to the small cationic salivary antimicrobial peptide histatin 5.

Authors:  C Gyurko; U Lendenmann; R F Troxler; F G Oppenheim
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

3.  Role of ATP-binding-cassette transporter genes in high-frequency acquisition of resistance to azole antifungals in Candida glabrata.

Authors:  D Sanglard; F Ischer; J Bille
Journal:  Antimicrob Agents Chemother       Date:  2001-04       Impact factor: 5.191

4.  Relationships between respiration and susceptibility to azole antifungals in Candida glabrata.

Authors:  Sophie Brun; Christophe Aubry; Osana Lima; Robert Filmon; Thierry Bergès; Dominique Chabasse; Jean-Philippe Bouchara
Journal:  Antimicrob Agents Chemother       Date:  2003-03       Impact factor: 5.191

5.  Enhancement of amphotericin B activity against Candida albicans by superoxide radical.

Authors:  Yuichi Okamoto; Shigeji Aoki; Izumi Mataga
Journal:  Mycopathologia       Date:  2004-07       Impact factor: 2.574

6.  Hypersusceptibility to azole antifungals in a clinical isolate of Candida glabrata with reduced aerobic growth.

Authors:  Patrick Vandeputte; Guy Tronchin; Françoise Rocher; Gilles Renier; Thierry Bergès; Dominique Chabasse; Jean-Philippe Bouchara
Journal:  Antimicrob Agents Chemother       Date:  2009-04-20       Impact factor: 5.191

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.